Viewing Study NCT01021059


Ignite Creation Date: 2025-12-24 @ 2:59 PM
Ignite Modification Date: 2026-01-01 @ 9:10 PM
Study NCT ID: NCT01021059
Status: COMPLETED
Last Update Posted: 2019-11-08
First Post: 2009-11-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module